Protein (2)
Launched (2)
Mouse (2)
His Tag (1)His Tag & Avi Tag (1)
Unconjugated (1)Biotin-labeled (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
FC4-M52H3 | HEK293 | Mouse Fc gamma RIV / CD16-2 Protein, His Tag (MALS verified) | ![]() | |||
FC4-M82E8 | HEK293 | Biotinylated Mouse Fc gamma RIV / CD16-2 Protein, His,Avitag™ (HPLC & BLI verified) | ![]() |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Cepeprubart | SelK-2 | Phase 2 Clinical | Selexys | Venous Thromboembolism; Asthma; Pulmonary Disease, Chronic Obstructive | Details |
| Leiolizumab | AbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268 | Phase 2 Clinical | Altrubio Inc | Colitis, Ulcerative; Arthritis, Psoriatic | Details |
| Neihulizumab | AbGn-168; AbGn-168H; ALTB-168 | Phase 1 Clinical | Altrubio Inc | Graft vs Host Disease; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic | Details |
| SSGJ-617 | SSGJ-617; SSGJ617; 61X; VTX-0811; 617 | Phase 1 Clinical | Verseau Therapeutics Inc | Solid tumours | Details |



BettinastraBe 30, 60325 Frankfurt am Main





